Hepatitis B virus surface antigen seroconversion after pegylated interferon-alpha treatment in an HIV-infected individual with chronic hepatitis B

被引：3
|
作者：
Rossetti, B. [1 ]
Bianco, C. [1 ]
De Luca, A. [1 ]
机构：
[1] Univ Siena, Policlin Le Scotte, Div Infect Dis 2, I-53100 Siena, Italy
来源：
INFECTION | 2012年 / 40卷 / 03期
关键词：
ACTIVE ANTIRETROVIRAL THERAPY; COMBINATION THERAPY; COINFECTION; PATIENT; HBV;
D O I：
10.1007/s15010-011-0198-1
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：347 / 349
页数：3
相关论文
共 50 条
  • [1] Hepatitis B virus surface antigen seroconversion after pegylated interferon-alpha treatment in an HIV-infected individual with chronic hepatitis B
    B. Rossetti
    C. Bianco
    A. De Luca
    Infection, 2012, 40 : 347 - 349
  • [2] Hepatitis B virus surface antigen seroconversion in HIV-infected individual after pegylated interferon-alpha treatment: a case report
    Delicio, Adriane Maira
    Martins Abati, Paulo Afonso
    Vigani, Aline Gonzalez
    JOURNAL OF VENOMOUS ANIMALS AND TOXINS INCLUDING TROPICAL DISEASES, 2013, 19
  • [3] Current treatment for chronic hepatitis C virus/HIV-infected individuals: the role of pegylated interferon-alpha and ribavirin
    Bhagani, Sanjay
    CURRENT OPINION IN HIV AND AIDS, 2011, 6 (06) : 483 - 490
  • [4] Comparison of hepatitis B virus core-related antigen and hepatitis B surface antigen for predicting HBeAg seroconversion in chronic hepatitis B patients with pegylated interferon therapy
    Wang, Meng-Lan
    Liao, Juan
    Wei, Bing
    Zhang, Dong-Mei
    He, Ming
    Tao, Ming-Chuan
    Chen, En-Qiang
    Tang, Hong
    INFECTIOUS DISEASES, 2018, 50 (07) : 522 - 530
  • [5] The different immune response of B cells specific for hepatitis B virus core and envelope antigen in chronic hepatitis B patients with pegylated interferon-alpha treatment
    Zheng, Qi
    Lai, Ruimin
    Zhang, Jiawei
    JOURNAL OF HEPATOLOGY, 2023, 78 : S1144 - S1144
  • [6] Interferon alpha treatment leads to a high rate of hepatitis B surface antigen seroconversion in Chinese children with chronic hepatitis B
    Fan, Huimin
    Lin, Luping
    Jia, Shijie
    Xie, Min
    Luo, Chun
    Tan, Xinghua
    Ying, Ruosu
    Guan, Yujuan
    Li, Feng
    JOURNAL OF VIRAL HEPATITIS, 2019, 26 : 77 - 84
  • [7] The impact of hepatitis B surface antigen seroconversion on the durability of functional cure induced by pegylated interferon alpha treatment
    Zhang, Wencong
    Chen, Jia
    Sun, Wenjin
    Xie, Nana
    Tian, Fangbing
    Ruan, Qiurong
    Song, Jianxin
    VIROLOGY JOURNAL, 2024, 21 (01)
  • [8] Pegylated Interferon Alpha for Chronic Hepatitis B Virus Infection
    Vasconcelos, Joana
    Domingos, Joao
    Bastos, Lia
    Baptista, Teresa
    Mansinho, Kamal
    Dkhil, Mohamed A.
    CASE REPORTS IN INFECTIOUS DISEASES, 2022, 2022
  • [9] Seroconversion of Hepatitis B Virus Surface Antigen in Chronic Hepatitis B Child Treated with Entecavir
    Li, Dong
    Wang, Junping
    Zhou, Junqing
    Wang, Yan
    NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES, 2012, 4 (09) : 427 - 428
  • [10] Hepatitis B surface antigen loss rate and safety and discontinuations with pegylated interferon alpha in chronic hepatitis B virus infection, a systematic review
    Gielen, Vera
    Kaur, Amandeep
    Kumar, Krishna
    Kharawala, Saifuddin
    Das, Joyeta
    Vincent, Jacob
    Mahajan, Anadi
    JOURNAL OF HEPATOLOGY, 2023, 78 : S1145 - S1145
12345